Innovative stents and scaffolds: potential of new technologies for your cathlab

Chairperson: C.K. Naber
Co-chairperson: R. Gao
Panellists: P.W. Serruys, Y. Yang

Learning Objectives

  • To exchange about innovative technologies developed in the Asia-Pacific region
  • To discuss specific indications of novel stents and scaffolds
  • To learn about the potential of novel drug delivery systems

Presentations available when logged in:

  • Sirolimus-eluting stent with abluminal groove-filled bioresorbable polymer (MicroPort, China)
  • Cobalt chromium-based bioresorbable polymer sirolimus-eluting stent (JW Medical Systems, China)
  • Bioresorbable polymer target release rapamycin-eluting scaffold (Huaan Biotech, China)
  • A novel biodegradable PLLA-based sirolimus-eluting scaffold (Microport, China)
  • Sirolimus-eluting fully bioresorbable scaffold with mixed PLLA/PDLA (ART/Terumo, France/Japan)
  • Fully bioresorbable PLLA-based sirolimus-eluting MeRes 100 scaffold (Meril Life Science, India)
  • Nano-microsphere for drug elution (Envision Scientific and Concept Medical, India)
  • Bioresorbable polymer sirolimus-eluting stent with electro-grafting base layer (Sinomed, China)